These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3611882)

  • 21. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a new ovarian tumor line in nude mice and its application to treatment of the donor patient.
    Sawada M; Matsui Y; Okudaira Y
    Gynecol Oncol; 1985 Jul; 21(3):320-30. PubMed ID: 4007611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    J Natl Cancer Inst; 1983 Dec; 71(6):1221-5. PubMed ID: 6197552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estimation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 5-FU concentrations in sera and resected specimens from patients with ovarian tumors].
    Takizawa K; Ino Y; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):697-702. PubMed ID: 3355187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil.
    Kusumoto T; Maehara Y; Sakaguchi Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):477-81. PubMed ID: 2703002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral HCFU for prevention of hepatic metastasis in an experimental colorectal carcinoma.
    Ito K; Wang L; Ye C; Ando H; Hibi K; Hidemura K; Akiyama S; Kasai Y; Nakao A
    Anticancer Res; 2001; 21(2A):899-904. PubMed ID: 11396182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    Biken J; 1983 Dec; 26(4):169-73. PubMed ID: 6204635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
    Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma.
    Yamamoto M; Arii S; Sugahara K; Tobe T
    Br J Surg; 1996 Mar; 83(3):336-40. PubMed ID: 8665186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antitumor effects of human interferon on human tumors heterotransplanted into nude mice].
    Sawada M; Oshikane M; Matsui Y; Okudaira Y; Kawashima M; Iwanaga K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1559-65. PubMed ID: 6182258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
    Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic fate on 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180.
    Iigo M; Kuretani K; Hoshi A
    J Natl Cancer Inst; 1981 Feb; 66(2):345-9. PubMed ID: 6935483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
    Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
    J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
    Yamauchi M; Satta T; Ito A; Kondo K; Akiyama S; Ito K; Watanabe T; Takagi H
    J Surg Oncol; 1991 Jun; 47(2):98-101. PubMed ID: 1905767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [1-Hexylcarbamoyl-5-fluorouracil (HCFU) effective in hepatocellular carcinoma metastatic to the lungs--a case report].
    Higashi H; Takenaka K; Kanematsu T; Matsumata T; Yoshida Y; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2956-9. PubMed ID: 2821925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
    Akiharu W; Higashi T; Kobayashi M; Nakatsukasa H; Fujiwara M; Shiota T; Yamauchi Y; Ito T; Yamamoto H; Nagashima H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2506-12. PubMed ID: 6095760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
    Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
    Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.